![Marco Zingg](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Marco Zingg
Direktor/Vorstandsmitglied bei 4D Lifetec AG
Aktive Beziehungen
Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
---|---|---|---|---|
Arne C. Faisst | M | - |
4D Lifetec AG
![]() 4D Lifetec AG BiotechnologyHealth Technology 4D Lifetec AG is a Swiss startup that specializes in developing the 4D Lifetest™, a liquid biopsy assay for the early detection of cancer. The company is based in Cham, Switzerland. The Swiss company's products for genotox applications are already commercially available, and they are currently working on future products for Integral Liquid Biopsy. The company's vision is to establish a test system for effective early cancer diagnostics and create a door opener to cancer prediction. The company was founded in 2014 by Nick Mijnssen. Arne C. Faisst has been the CEO of the company since 2014. | 10 Jahre |
Nick Mijnssen | M | - |
4D Lifetec AG
![]() 4D Lifetec AG BiotechnologyHealth Technology 4D Lifetec AG is a Swiss startup that specializes in developing the 4D Lifetest™, a liquid biopsy assay for the early detection of cancer. The company is based in Cham, Switzerland. The Swiss company's products for genotox applications are already commercially available, and they are currently working on future products for Integral Liquid Biopsy. The company's vision is to establish a test system for effective early cancer diagnostics and create a door opener to cancer prediction. The company was founded in 2014 by Nick Mijnssen. Arne C. Faisst has been the CEO of the company since 2014. | 10 Jahre |
Rainer Metzger | M | - |
4D Lifetec AG
![]() 4D Lifetec AG BiotechnologyHealth Technology 4D Lifetec AG is a Swiss startup that specializes in developing the 4D Lifetest™, a liquid biopsy assay for the early detection of cancer. The company is based in Cham, Switzerland. The Swiss company's products for genotox applications are already commercially available, and they are currently working on future products for Integral Liquid Biopsy. The company's vision is to establish a test system for effective early cancer diagnostics and create a door opener to cancer prediction. The company was founded in 2014 by Nick Mijnssen. Arne C. Faisst has been the CEO of the company since 2014. | - |
Beziehungs-Chart
Beziehungen zu mehreren Unternehmen
Statistik
Land | Beziehungen | % des Gesamten |
---|---|---|
Schweiz | 3 | 100,00% |
Alter der Beziehungen
Aktive
Vergangene
Herr
Frau
Aufsichtsräte
Führungskräfte
Ursprung der Beziehungen
- Börse
- Insiders
- Marco Zingg
- Persönliches Netzwerk